Workflow
XI'AN XICE TESTING TECHNOLOGY CO.(301306)
icon
Search documents
西测测试(301306) - 简式权益变动报告书
2025-09-12 10:44
西安西测测试技术股份有限公司 简式权益变动报告书 上市公司名称:西安西测测试技术股份有限公司 股票上市地点:深圳证券交易所 信息披露义务人声明 本部分所述词语或简称与本报告书"释义"所述词语或简称具有相同含义。 股票简称:西测测试 股票代码:301306 信息披露义务人 1:宁波梅山保税港区丰年君悦投资合伙企业(有限合伙) 住所:浙江省宁波市北仑区梅山七星路 88 号 1 幢 401 室 A 区 H1330 通讯地址:北京市朝阳区东三环中路 5 号楼 信息披露义务人 2:成都川创投丰年君传军工股权投资基金合伙企业(有限合伙) 住所:中国(四川)自由贸易试验区成都高新区剑南大道中段 1098 号 1 栋 23 层 2301 号 通讯地址:北京市朝阳区东三环中路 5 号楼 信息披露义务人 3:宁波梅山保税港区丰年君和创业投资合伙企业(有限合伙) 住所:浙江省宁波市北仑区梅山七星路 88 号 1 幢 401 室 A 区 H1331 通讯地址:北京市朝阳区东三环中路 5 号楼 股份变动性质:减少股份(合计持股比例降至 5%以下) 签署日期:2025 年 9 月 一、本报告书系依据《中华人民共和国公司法》《中华人民共和 ...
西测测试跌2.03%,成交额7749.33万元,主力资金净流出682.33万元
Xin Lang Cai Jing· 2025-09-12 03:22
9月12日,西测测试盘中下跌2.03%,截至10:52,报53.98元/股,成交7749.33万元,换手率2.43%,总市 值45.56亿元。 资金流向方面,主力资金净流出682.33万元,特大单买入113.80万元,占比1.47%,卖出332.49万元,占 比4.29%;大单买入950.89万元,占比12.27%,卖出1414.53万元,占比18.25%。 西测测试所属申万行业为:国防军工-军工电子Ⅱ-军工电子Ⅲ。所属概念板块包括:军民融合、大飞 机、商业航天(航天航空)、航天军工、小盘等。 截至6月30日,西测测试股东户数1.69万,较上期增加66.47%;人均流通股2329股,较上期减少 39.93%。2025年1月-6月,西测测试实现营业收入1.48亿元,同比减少33.43%;归母净利润-6040.63万 元,同比减少22.94%。 分红方面,西测测试A股上市后累计派现1266.00万元。 机构持仓方面,截止2025年6月30日,西测测试十大流通股东中,广发科技创新混合A(008638)位居 第七大流通股东,持股81.01万股,为新进股东。广发价值核心混合A(010377)位居第十大流通股东, 持股2 ...
西测测试(301306.SZ):为多家卫星相关产业链客户提供电装及检测服务
Ge Long Hui· 2025-09-09 07:23
格隆汇9月9日丨西测测试(301306.SZ)在互动平台表示,公司为多家卫星相关产业链客户提供电装及检 测服务。公司的主要客户属于重要经营信息,且均签署了保密协议,无法披露。 ...
西测测试跌2.08%,成交额3006.96万元,主力资金净流入282.94万元
Xin Lang Cai Jing· 2025-09-03 02:40
9月3日,西测测试盘中下跌2.08%,截至09:54,报55.90元/股,成交3006.96万元,换手率0.92%,总市 值47.18亿元。 资金流向方面,主力资金净流入282.94万元,大单买入660.58万元,占比21.97%,卖出377.64万元,占 比12.56%。 西测测试今年以来股价涨49.59%,近5个交易日跌8.66%,近20日跌20.70%,近60日涨9.74%。 今年以来西测测试已经4次登上龙虎榜,最近一次登上龙虎榜为7月4日,当日龙虎榜净买入-6910.72万 元;买入总计1.42亿元 ,占总成交额比13.84%;卖出总计2.11亿元 ,占总成交额比20.59%。 责任编辑:小浪快报 资料显示,西安西测测试技术股份有限公司位于陕西省西安市高新区丈八二路16号,成立日期2010年6 月1日,上市日期2022年7月26日,公司主营业务涉及从事军用装备和民用飞机产品检验检测,为客户提 供环境与可靠性试验、电子元器件检测筛选、电磁兼容性试验等检验检测服务,同时开展检测设备的研 发、生产和销售以及电装业务。主营业务收入构成为:环境与可靠性试验49.49%,电子装联业务 29.38%,电磁兼容性试验 ...
西测测试20250902
2025-09-02 14:41
Summary of the Conference Call Company Overview - The company focuses on the entire commercial aerospace industry chain, covering low-altitude economy, high-altitude, and space sectors, with core competencies in electronic component quality assurance, manufacturing, and inspection services [2][5][10] - The company has rapidly increased its production capacity to approximately 2 billion yuan post-IPO, although second-quarter performance declined due to changes in project accounting methods and delays in project confirmations [2][8][19] Key Business Developments - The company has established a one-stop service model to expand market share and has formed partnerships with companies like Blue Arrow and CASIC [2][10] - In the aerospace sector, revenue for the first half of 2025 was approximately 38 million yuan, with inspection services accounting for over 90% of this revenue [2][13] - The company has a satellite testing equipment utilization rate of about 70%-80%, while manufacturing utilization is lower, but efforts are underway to improve this through strategic partnerships [2][20] Financial Performance - The second-quarter decline in performance was attributed to a shift in revenue recognition methods and delays in project confirmations, but overall operations remain stable [8][19] - The company expects to achieve annual revenue of 102 million yuan in the aerospace sector for 2025, representing a significant increase from the previous year's revenue of over 20 million yuan [19] Strategic Initiatives - The company plans to enhance missile production capacity to 20,000 units annually and is actively pursuing diversification into large aircraft, renewable energy, and nuclear energy sectors [3][24] - The company is also focusing on military informationization and the construction of a comprehensive aerospace system [23] Market Position and Competitive Advantage - The company is the only domestic entity with multiple aerospace certifications and has established a unique position in the commercial aerospace value chain [10][11][12] - Collaborations with major companies like Huawei have solidified its market position, with Huawei considering the company a rare resource due to its comprehensive testing capabilities [20] Future Outlook - The company anticipates continued growth in the aerospace sector, driven by increasing market demand and enhanced capabilities [14][21] - Future revenue growth will depend on the overall industry development pace and the company's ability to secure large-scale production tasks [19] Challenges and Risks - The company faces pressure on net profit margins due to significant upfront investments and ongoing expenditures in new industry directions [25] - The need for continuous capacity expansion and the potential for further financing to support growth initiatives are acknowledged [26][28] Additional Business Directions - Besides commercial aerospace, the company is making strides in the large aircraft sector and low-altitude economy, ensuring a diversified business approach [29] Brand Awareness and Market Presence - The company is enhancing brand recognition through marketing initiatives and establishing a presence in key markets, aiming to attract high-quality clients [30] Conclusion - While current performance has not yet exploded, the company is optimistic about future growth, particularly in commercial aerospace and domestic large aircraft sectors, and encourages investor support [31]
时报图说丨社保基金最新持仓出炉 新进了这些股
Core Viewpoint - The latest holdings of the social security fund have been revealed, showing significant changes in stock positions as of June 30, 2025, following the completion of the semi-annual reports of listed companies [2]. Group 1: Top Holdings - The top ten stocks held by the social security fund, along with their holding ratios and changes, include: - Andar Intelligent: 11.90% (-1.53%) in specialized equipment manufacturing [3] - Changshu Bank: 8.38% (-0.05%) in monetary financial services [3] - Biyinlefen: 7.37% (-0.98%) in textile, clothing, and accessories [3] - Bai'ao Intelligent: 7.23% (new entry) in specialized equipment manufacturing [4] - Weixing Co.: 7.08% (+0.45%) in textile, clothing, and accessories [4] - Hehe Information: 7.00% (-0.27%) in software and information technology services [4] - Shantui Co.: 6.87% (+0.90%) in specialized equipment manufacturing [4] - Yongxing Co.: 6.53% (+4.30%) in ecological protection and environmental governance [4] - Xice Testing: 6.36% (-1.53%) in professional technical services [4] - Keri International: 6.30% (+0.60%) in business services [4] Group 2: New Holdings - New stock positions taken by the social security fund include: - Bai'ao Intelligent: 456.86 million shares (7.23%) in specialized equipment manufacturing [5] - Nossger: 217.08 million shares (3.80%) in research and experimental development [5] - Zhongchumei: 320.00 million shares (3.45%) in chemical raw materials and chemical products manufacturing [5] - Beiding Co.: 1,000.00 million shares (3.16%) in electrical machinery and equipment manufacturing [5] - Ugreen Technology: 100.00 million shares (3.01%) in computer, communication, and other electronic equipment manufacturing [5] - Sutest: 1,486.20 million shares (2.94%) in professional technical services [5] Group 3: Increased Holdings - The stocks with increased holdings by the social security fund include: - Yongxing Co.: 6.53% (+4.30%) in ecological protection and environmental governance [8] - Jiangshan Co.: 5.53% (+3.44%) in chemical raw materials and chemical products manufacturing [8] - Three squirrels: 3.78% (+2.79%) in retail [8] - Juhe Materials: 5.87% (+2.42%) in computer, communication, and other electronic equipment manufacturing [8] - Sanwei Chemical: 4.77% (+2.38%) in chemical raw materials and chemical products manufacturing [8] - Rujing Technology: 5.27% (+2.32%) in electrical machinery and equipment manufacturing [8] - Ziyou Intelligent-U: 4.12% (+2.12%) in pharmaceutical manufacturing [8] - Guoyao Co.: 4.03% (+1.95%) in wholesale [10] - Jinchengxin: 5.06% (+1.54%) in mining auxiliary activities [10] - Dingdian Software: 2.54% (+1.54%) in software and information technology services [10]
西测测试8月28日获融资买入3282.33万元,融资余额1.62亿元
Xin Lang Cai Jing· 2025-08-29 02:05
Group 1 - The core viewpoint of the news highlights the financial performance and trading activity of Xian Xice Testing Technology Co., Ltd., indicating a decline in stock price and significant changes in financing and shareholder structure [1][2][3] Group 2 - On August 28, Xice Testing's stock price fell by 3.73%, with a trading volume of 314 million yuan. The financing data shows a net financing outflow of 7.19 million yuan for the day, with a total financing balance of 162 million yuan, representing 3.25% of the circulating market value [1] - The company reported a 33.43% year-on-year decrease in operating income for the first half of 2025, amounting to 148 million yuan, and a net profit attributable to shareholders of -60.41 million yuan, a 22.94% decrease year-on-year [2] - The main business revenue composition includes environmental and reliability testing (49.49%), electronic assembly business (29.38%), electromagnetic compatibility testing (10.81%), electronic component testing (8.18%), and sales of testing equipment (1.88%) [2] - As of June 30, 2025, the number of shareholders increased by 66.47% to 16,900, while the average circulating shares per person decreased by 39.93% to 2,329 shares [2] - The company has distributed a total of 12.66 million yuan in dividends since its A-share listing [3] - Notable institutional holdings include new shareholders such as GF Technology Innovation Mixed A and GF Value Core Mixed A, while Bosera Military Industry Theme Stock A has exited the top ten circulating shareholders [3]
西测测试2025年中报简析:净利润同比下降22.94%,三费占比上升明显
Zheng Quan Zhi Xing· 2025-08-29 00:02
Core Viewpoint - The recent financial report of Xicetest (301306) indicates a significant decline in revenue and profit, highlighting challenges in the company's business model and financial health [1][2]. Financial Performance Summary - Total revenue for the first half of 2025 was 148 million yuan, a year-on-year decrease of 33.43% compared to 222 million yuan in 2024 [1]. - The net profit attributable to shareholders was -60.41 million yuan, down 22.94% from -49.14 million yuan in the previous year [1]. - The gross margin fell to 6.87%, a decrease of 37.88% from 11.07% in 2024, while the net margin dropped to -40.45%, down 88.06% from -21.51% [1]. - The total of selling, administrative, and financial expenses reached 57.03 million yuan, accounting for 38.56% of total revenue, an increase of 52.33% year-on-year [1]. Cash Flow and Debt Analysis - The company reported a significant increase in interest-bearing liabilities, which rose by 95.75% to 368 million yuan from 188 million yuan [1]. - The average operating cash flow over the past three years is negative, indicating potential liquidity issues [2]. Business Model and Market Position - The company operates as a third-party inspection and testing service provider for military and civil aviation products, offering a comprehensive range of services including environmental and reliability testing [3]. - It has established a strong brand reputation, which aids in attracting new business opportunities [3].
西测测试:上半年现金流大幅改善114% “军工”“航天”双轮驱动 助力“中国智造”
Core Viewpoint - The company, Xicetest, has shown significant improvement in cash flow despite reporting a net loss in the first half of 2025, indicating potential for future growth in the aerospace and military sectors driven by national strategies [1][2]. Financial Performance - In the first half of 2025, Xicetest achieved operating revenue of 148 million yuan, with a net profit attributable to shareholders of -61.24 million yuan. However, cash flow from operating activities improved by 114.07% compared to the same period last year [1]. Business Segments - Xicetest's revenue breakdown for the first half of the year includes: - Environmental and reliability testing: 73.19 million yuan - Electromagnetic compatibility testing: 15.98 million yuan - Electronic assembly services: 43.44 million yuan - Electronic component testing and selection: 12.09 million yuan - The business structure reflects a dual-driven model from military and commercial aerospace sectors [2]. Strategic Initiatives - The company has established a wholly-owned subsidiary in Wenchang, Hainan, to align with national commercial aerospace strategies and integrate into the Wenchang International Aerospace City industrial cluster [3]. - Xicetest has introduced the concept of "Equipment Hospital," extending testing services to the maintenance phase of military equipment, thereby enhancing reliability testing across the entire lifecycle of military and aerospace equipment [4]. Collaborations and Innovations - A strategic partnership has been formed with Xi'an Jiaotong University to establish a research institute focused on military and aerospace equipment reliability, addressing challenges under various environmental conditions [5]. - The company has recently obtained AS9100 certification, which is recognized as a prerequisite for entering the aerospace industry, thereby solidifying its position in the low-altitude economy and commercial aerospace sectors [4]. Long-term Vision - Xicetest is committed to supporting the "China Intelligent Manufacturing" initiative, aiming to enhance production quality and contribute to the development of new productive forces during the 14th Five-Year Plan [6][7]. - The company anticipates significant growth opportunities in the commercial aerospace market, projecting that the market will exceed one trillion yuan, with potential for multiple billion-yuan industry clusters to emerge [7][8].
西测测试:8月26日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-27 23:30
Group 1 - The company, Xicet Testing, announced the convening of its 25th second board meeting on August 26, 2025, to review the proposal regarding the full text and summary of the 2025 semi-annual report [1] - The meeting took place in the company's conference room [1] Group 2 - The news highlights a significant medical advancement with the world's first successful transplantation of gene-edited pig lungs into a human [1] - A dialogue with key participants indicates that there is still a distance to clinical application [1]